“Nanotechnology has the potential to generate enormous health benefits for the more than five billion people living in the developing world,” according to Dr. Peter A. Singer, senior scientist at the McLaughlin-Rotman Centre for Global Health and Professor of Medicine at University of Toronto.
Mylan Laboratories Inc. today announced that Mylan Pharmaceuticals Inc. has received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Ondansetron Orally Disintegrating Tablets USP, 4mg and 8mg strengths.
Daiei Trading-Chicago-Co., Inc. of Carol Stream, Illinois is recalling 8.8 oz packages of Bean Cracker, “Itomo Mame Mix” because it contains undeclared peanuts.
Bristol-Myers Squibb Company (NYSE: BMY) and Adnexus(TM) Therapeutics today announced a worldwide strategic alliance to discover, develop and commercialize Adnectin-based therapeutics for important oncology-related targets.
The U.S. Food and Drug Administration (FDA) has approved the antidepressant Cymbalta(R) (duloxetine HCl) for the treatment of generalised anxiety disorder (GAD), Eli Lilly and Company (NYSE: LLY) and Boehringer Ingelheim announced today.
Dr. Vafa Shahabi and her research team at Advaxis have designed several new strains of the Listeria bacteria that are programmed to kill off specific cancers.
A controversial health centre where NHS patients will be treated by a private company has been opened.
Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has approved more convenient patient storage instructions for BYETTA? (exenatide) injection.
Eli Lilly and Company today announced the launch of the first insulin pen with memory, HumaPen? MEMOIR?, to help simplify the daily management of diabetes.